Flaga, Reygine G.

HRN: 26-61-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/26/2025
02/09/2025
IV
600 Mg
Q8H
Open Fracture
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: